Covered
BKSY · BlackSky Technology Inc.
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on the last session; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A daily close below $16.00, under the $16.54 low of the range in which the CEO sold shares on 20 October 2026. A cut to the FY2026 revenue guide of $130M–$150M, or a Gen-3 schedule that slips with no replacement date, would also break the case.
Not a pickResearch coverage at low conviction. A medium-or-higher call would open a pick on the scoreboard.
Catalyst (1 day ago)
How picks are graded →The thesis
BlackSky's Gen-3 satellite rollout and sovereign-customer demand still support a recovery case, but the shares closed at $19.11 on 28 October 2026, 63.0% below the 52-week high of $51.63. The Q3 report on 5 November 2026 settles whether revenue, Gen-3 pace and cash use confirm the case.
The company confirmed on 19 October 2026 that it will release Q3 results and hold its call on Thursday 5 November 2026 at 8:30 a.m. Eastern. Unusual Whales listed an expected earnings move of roughly 20% as of 6 October 2026.
The narrative is maturing: company contract releases have arrived on 8 October 2026, 19 October 2026 and 22 October 2026, yet the shares fell 17.1% over three months to the 28 October 2026 close. The 14-day relative strength index (RSI) is 39.2, up from 27.2 on 15 October 2026. Conviction stays low because the price has not responded to small contract news, the CEO sold shares on 20 October 2026, and equity supply remains open.
Bullish and bearish views on BlackSky Technology Inc.
The bull case on BlackSky Technology Inc. (BKSY), in brief: Revenue growth is measured. The bear case: Insider selling at lower prices.
Bull case
- Revenue growth is measured. Q2 revenue was $33.316M against a $30.68M analyst estimate, up 50% year over year, with adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of $4.7M (company results, 6 August 2026).
- Guidance was affirmed. BlackSky kept FY2026 revenue guidance at $130M–$150M on 6 August 2026, against a $136.96M analyst estimate (Benzinga).
- Defense customers keep signing. BlackSky announced a seven-figure Gen-3 Assured contract expansion with an international defense partner on 22 October 2026, a seven-figure HEO non-Earth imaging contract on 19 October 2026 and a seven-figure multi-year international subscription on 11 August 2026 (company news).
- Capacity is arriving. The fifth Gen-3 satellite produced imagery less than 20 hours after liftoff (company release, 14 September 2026). CEO Brian O'Toole set a goal of eight to nine Gen-3 satellites on orbit by end-2026 (Aviation Week, 26 February 2026).
- Analysts sit far above the price. The consensus target was $38.42 from six analysts, with targets from $33.00 to $42.50 (stockanalysis.com, 2 October 2026).
Bear case
- Insider selling at lower prices. CEO Brian O'Toole sold 20,000 Class A shares at a weighted average of $16.86 on 20 October 2026 under a trading plan adopted in June 2026, leaving 1,023,396 shares held directly (SEC Form 4, signed 22 October 2026).
- Earnings missed despite the revenue beat. Q2 EPS was $(0.54) against $(0.36) expected (Benzinga, 6 August 2026).
- Equity supply is open. BlackSky raised $150M through its at-the-market program in Q2, and the $250M program remains live (Q2 results, 6 August 2026). Sales into a rally would cap the move.
- The Q3 deployment goal is unconfirmed. The 6 August 2026 outlook anticipated two more Gen-3 satellites in Q3, and only the fifth has been reported. Company headlines through 23 October 2026 announced no launch date for the sixth.
- Contract values are small or undisclosed. The recent awards are described only as six-figure or seven-figure, against an FY2026 revenue guide of $130M–$150M.
- Revenue is lumpy. More than 80% of funded backlog is international sovereign customers (6 August 2026 earnings call), so one delayed contract can move a quarter.
Price setup
The adjusted close was $19.11 on 28 October 2026. That is 63.0% below the 52-week high of $51.63 and 17.1% lower than three months earlier.
The CEO's 20 October 2026 sales traded between $16.54 and $17.32 (SEC Form 4), so the shares have since closed higher than that range. The $20.50 close of 4 September 2026, which the prior note treated as the level that gave way, sits above the current close.
The RSI of 39.2 has come off the oversold reading of 27.2 on 15 October 2026. It sits far below the 79.1 reading at the $30.92 close of 14 August 2026. A 20% expected earnings move implies the 5 November 2026 report can reprice the shares in either direction.
Catalysts, next 30 days
- Undated: Launch window for the sixth Gen-3 satellite. A date would show whether the year-end target of eight to nine holds.
Elapsed catalysts
- 5 November 2026, 8:30 a.m. Eastern: Q3 2026 results and call. Revenue against the $130M–$150M guide, the Gen-3 launch count, cash use and any new at-the-market proceeds decide whether the recovery case holds (company announcement, 19 October 2026). (passed 1d ago)
- After the report: The Q3 10-Q shows the share count, which stood at 40.92M at 5 September 2026 per stockanalysis.com, and any change from at-the-market sales. (passed 62d ago)
What would change the view
The case breaks if the Q3 report cuts the FY2026 revenue guide of $130M–$150M, or if Q3 revenue leaves the guide dependent on an unusually large Q4. It also breaks if the Gen-3 schedule slips with no replacement date, or if the 10-Q shows a materially higher share count from at-the-market sales.
On price, a daily close below $16.00 would put the shares under the low of the CEO's 20 October 2026 sale range. A report that ties disclosed contract value or backlog to the recent seven-figure awards, together with a dated sixth-satellite launch, would strengthen the case.
What it trades with
BlackSky trades with small-cap space and defense-technology names and with Gen-3 imagery peers that depend on government demand. With 40.92M shares outstanding (stockanalysis.com, 5 September 2026), modest dollar flow moves the price sharply. The $185.0M of 8.25% convertible notes due 2033 convert at about $36.78 per share, which sits near the low end of the analyst target range of $33.00 to $42.50.
Notes
- A $250M at-the-market equity program (Deutsche Bank Securities, Craig-Hallum) was established 22 May 2026 and was reported live in the 6 August 2026 results; the share count can rise between filings.
- $185.0M of 8.25% convertible senior notes due 2033 were outstanding at 30 June 2026;
- Over 80% of funded backlog is international sovereign customers per the 6 August 2026 earnings call, so quarterly revenue moves with contract timing.
- Shares outstanding were 40.92M per stockanalysis.com at 5 September 2026; a small share count means modest dollar flow can move the price sharply.
- Analyst coverage counts differ by source (8 per S&P Global at 12 August 2026, 6 per stockanalysis.com); the consensus target was $38.42 on both.
Related · shared themes
ARXS
Arxis, Inc.
Arxis, a roll-up of defense, space and industrial component makers, posted 29% organic growth and raised its 2026 outlook on 28 October…
LMT
Lockheed Martin Corporation
Lockheed Martin's record $292.0 billion backlog and raised 2026 guidance still support the shares after the post-election selloff; the…
RTX
RTX Corporation
RTX Corporation's record $340 billion backlog and raised 2026 guidance still outweigh the selloff after the midterm elections; a full-year…
ASTS
AST SpaceMobile, Inc.
AST SpaceMobile has to prove it can launch satellites and start paid phone service on time as SpaceX pushes into U.S. wireless; the 9…